Bulletin 2011/27 - European Patent Office

(C07D) I.1(1)
(51) C07D 277/36 (11) 2 340 245 A2*
A61K 31/25 A61K 31/20
A61P 3/10
(25) En (26) En
(21) 09801070.5 (22) 24.07.2009
(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB
GR HR HU IE IS IT LI LT LU LV MC MK MT
NL NO PL PT RO SE SI SK SM TR
AL BA RS
(86) US 2009/051693 24.07.2009
(87) WO 2010/011926 2010/04 28.01.2010
(88) 27.05.2010
(30) 25.07.2008 US 83619 P
(54) • NEUER BETAINKOKRISTALL VON EPAL-
RESTAT
• A NOVEL BETAINE COCRYSTAL OF EPAL-
RESTAT
• NOUVEAU CO-CRISTAL DE BÉTAÏNE
D'ÉPALRESTAT
(71) Bionevia Pharmaceuticals Inc., 1 Nichols
Place, Cambridge, MA 02138, US
(72) KALOFONOS, Isabel, Cambridge MA 02138,
US
STAHLY, Patrick, G., West Lafayette IN
47906, US
MARTIN-DOYLE, William, Cambridge MA
02141, US
KALOFONOS, Dimitris, Cambridge MA
02138, US
STULTS, Jeffrey, S., West Lafayette IN
47906, US
HOUSTON, Travis, L., Lafayette IN 47909,
US
(74) Cottrill, Emily Elizabeth Helen, A.A. Thornton
& Co. 235 High Holborn, London WC1V 7LE,
GB
C07D 307/16 → (51) C07C 259/06
C07D 307/81 → (51) C07C 259/06
C07D 309/22 → (51) C07C 259/06
C07D 317/44 → (51) C07D 487/04
(51) C07D 319/20 (11) 2 340 246 A2*
(25) En (26) En
(21) 09798447.0 (22) 19.06.2009
(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB
GR HR HU IE IS IT LI LT LU LV MC MK MT
NL NO PL PT RO SE SI SK TR
AL BA RS
(86) US 2009/048026 19.06.2009
(87) WO 2010/008776 2010/03 21.01.2010
(88) 07.04.2011
(30) 23.06.2008 US 74783 P
(54) • KRISTALLINE FORM VON (2S)-(-)-N-(6-
CHLOR-2,3-DIHYDROBENZO[1,4] DIOXIN-
2-YLMETHYL)SULFAMID
• CRYSTALLINE FORM OF (2S)-(-)-N-(6-
CHLORO-2,3-DIHYDRO-BENZO[1,4]
DIOXIN-2-YLMETHYL)-SULFAMIDE
• FORME CRYSTALLINE DE (2S)-(-)-N-(6-
CHLORO-2,3-DIHYDRO-BENZO[1,4]DIO-
XIN-2-YLMETHYL)-SULFAMIDE
(71) Janssen Pharmaceutica, N.V., Turnhoutseweg
30, 2340 Beerse, BE
(72) MEHRMAN, Steven, J., Quakertown PA
18951, US
WU, Wenju, Hillsborough NJ 08844, US
(74) Warner, James Alexander, Carpmaels &
Ransford One Southampton Row, London
WC1B 5HA, GB
(51) C07D 401/00 (11) 2 340 247 A1*
(25) En (26) En
(21) 09819655.3 (22) 29.09.2009
Europäisches Patentblatt
European Patent Bulletin
Bulletin européen des brevets
(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB
GR HR HU IE IS IT LI LT LU LV MC MK MT
NL NO PL PT RO SE SI SK SM TR
AL BA RS
(86) US 2009/058763 29.09.2009
(87) WO 2010/042347 2010/15 15.04.2010
(30) 06.10.2008 US 195302 P
(54) • POSITIVE ALLOSTERE MODULATOREN
DES CHINOLIZIDINON-M1-REZEPTORS
• QUINOLIZIDINONE M1 RECEPTOR POSI-
TIVE ALLOSTERIC MODULATORS
• MODULATEURS ALLOSTÉRIQUES POSI-
TIFS DU RÉCEPTEUR M1 DE LA QUINO-
LIZIDINONE
(71) Merck Sharp & Dohme Corp., 126 East
Lincoln Avenue, Rahway, NJ 07065-0907,
US
(72) KUDUK, Scott, D., Rahway New Jersey
07065-0907, US
DI MARCO, Christina Ng, Rahway New
Jersey 07065-0907, US
(74) Buchan, Gavin MacNicol, Merck & Co., Inc.
European Patent Department Hertford Road,
Hoddesdon, Hertfordshire EN11 9BU, GB
C07D 401/04 → (51) C07D 209/42
C07D 401/06 → (51) A61K 31/40
C07D 401/12 → (51) A61K 31/40
C07D 401/12 → (51) C07D 403/14
C07D 401/14 → (51) A61K 31/40
C07D 401/14 → (51) C07D 209/42
C07D 401/14 → (51) C07D 403/14
C07D 403/04 → (51) C07D 209/42
C07D 403/06 → (51) A61K 31/40
C07D 403/12 → (51) A61K 31/40
C07D 403/12 → (51) C07D 403/14
(51) C07D 403/14 (11) 2 340 248 A2*
C07D 403/12 C07D 401/14
C07D 401/12 A61K 31/497
A61P 25/28
(25) En (26) En
(21) 09813799.5 (22) 15.09.2009
(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB
GR HR HU IE IS IT LI LT LU LV MC MK MT
NL NO PL PT RO SE SI SK SM TR
AL BA RS
(86) US 2009/056993 15.09.2009
(87) WO 2010/031056 2010/11 18.03.2010
(88) 05.08.2010
(30) 15.09.2008 US 97173 P
(54) • VERFAHREN UND ZUSAMMENSETZUN-
GEN ZUR MODULATION DER IRE1-, SRC-
UND ABL-AKTIVITÄT
• METHODS AND COMPOSITIONS FOR
MODULATING IRE1, SRC, AND ABL
ACTIVITY
• PROCÉDÉS ET COMPOSITIONS POUR
MODULER L ACTIVITÉ IRE1, SRC, ET ABL
(71) The Regents of the University of California,
1111 Franklin Street, 12th Floor, Oakland, CA
94607, US
(72) WALTER, Peter, San Francisco California
94122, US
KORENNYKH, Alexei, San Francisco, California
94158, US
SHOKAT, Kevan M., San Francisco California
94121, US
63
Anmeldungen
Applications
Demandes (27/2011) 06.07.2011
ZHANG, Chao, Santa Cruz California 95064,
US
FINER-MOORE, Janet, San Bruno California
94066, US
STROUD, Robert, San Francisco California
94116, US
EGEA, Pascal, San Francisco, California
94143, US
KOROSTELEV, Andrei, Santa Cruz, California
95062, US
DAR, Arvin, San Francisco, California 94158,
US
(74) Murray, Adrian D'Coligny, et al, W.P.
Thompson & Co. 55 Drury Lane, London
WC2B 5SQ, GB
C07D 403/14 → (51) C07D 209/42
C07D 405/04 → (51) C07D 487/04
C07D 405/06 → (51) A61K 31/40
C07D 405/12 → (51) A61K 31/40
C07D 405/12 → (51) C07D 209/42
C07D 405/12 → (51) C07D 487/04
C07D 409/04 → (51) A61K 31/40
C07D 409/04 → (51) C07D 209/42
C07D 409/12 → (51) A61K 31/40
C07D 409/14 → (51) C07D 209/42
C07D 413/04 → (51) C07D 209/42
C07D 413/12 → (51) A61K 31/40
(51) C07D 413/14 (11) 2 340 249 A1*
A61K 31/444 A61P 35/00
A61K 31/4439 A61K 31/496
(25) En (26) En
(21) 09756849.7 (22) 02.11.2009
(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB
GR HR HU IE IS IT LI LT LU LV MC MK MT
NL NO PL PT RO SE SI SK SM TR
AL BA RS
(86) IB 2009/054856 02.11.2009
(87) WO 2010/049915 2010/18 06.05.2010
(30) 31.10.2008 EP 08168104
(54) • POLYHETEROARYLDERIVATE ZUR
BEHANDLUNG VON KREBS
• POLY-HETEROARYL DERIVATIVES FOR
THE TREATMENT OF CANCER
• DÉRIVÉS DE POLY-HÉTÉROARYLE POUR
LE TRAITEMENT DU CANCER
(71) Institut Curie, 26, rue d'Ulm, 75248 Paris
Cedex 05, FR
Centre National de la Recherche Scientifique
(CNRS), 3, rue Michel-Ange, 75794 Paris
Cedex 16, FR
Institut National De La Sante Et De La
Recherche Medicale, 101 Rue de Tolbiac,
75654 Paris Cedex 05, FR
Museum National D'histoire Naturelle
(MNHN), 43 Rue Cuvier, 75231 Paris cedex
05, FR
(72) NGUYEN, Chi-Hung, F-92160 Antony, FR
ROUCHON DAGOIS, Myriam, F-91120 Palaiseau,
FR
GUEDIN-BEAUREPAIRE, Aurore, F-91240
Saint-Michel-sur-Orge, FR
MONCHAUD, David, F-21000 Dijon, FR
TEULADE-FICHOU, Marie-Paule, F-75014
Paris, FR
RIOU, Jean-François, F-75014 Paris, FR